Klaus Pohle

Operates as an investment holding company primarily investing in biotechnology

Manufactures plastic materials, precursors, chemicals for batteries, automotive OEM coatings, petrochemicals, intermediates, agrochemicals, industrial, nutrition & care additives

Manufactures pharmaceuticals and diagnostic substances

Provides commercial real estate financing

Engages in research, development and production of pharmaceuticals & vaccines

DWS Investment is an active, GARP-oriented manager which manages mutual funds invested globally across a broad range of asset classes, regions and sectors. They construct portfolios which take into account environmental, social and governance issues. They have particular expertise in German and international large-cap equities and seek to invest in companies with an attractive risk/reward profile in sectors such as healthcare, telecommunications, oil, alternative energies and infrastructure-related activities. The firm's investment philosophy emphasizes the reactivity and independence of small, dedicated investment teams, as well as close collaboration between equity, balanced, fixed-income and currency specialists. Their fundamental research process comprises an extensive program of company visits and management meetings. Their global network of analysts uses the proprietary G Cube Intranet-based research and communication platform which provides real-time access to information gathered locally. DWS Investment prefers to invest in strong companies in developed markets, targeting dividend-paying companies with a low gearing ratio and management teams with a proven track record. They utilize a bottom-up investment process based on a discounted cash flow model.

Manufactures and distributes organic & inorganic chemical products

Manufactures and distributes fragrances, skin care, cosmetics and body care products

Functions as a College/University